M
MedPayIQ
CPT 20610Surgery

Drain/inj joint/bursa w/o us

CPT code 20610 covers draining fluid from or injecting medication into a major joint (like a knee or shoulder) or bursa without using ultrasound guidance. This is a common outpatient procedure for treating conditions like arthritis, bursitis, or joint effusions.

Non-facility rate
$63.40
2025 Medicare national average
Facility rate
$43.99
2025 Medicare national average

RVU breakdown

Work RVU
0.79
PE RVU (NF)
1.04
MP RVU
0.13
Total RVU
1.96

Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High

Billing tips

  1. Verify site-of-service coding accuracy: Non-facility (office) rate is $63.40 vs. facility rate $43.99. The provider receives the lower rate when performed in hospital outpatient or ASC settings.

    Impact: Incorrect POS code costs $19.41 per procedure (44% reduction). For practices performing 200 injections yearly, this represents $3,882 in lost revenue.

  2. Bill for the medication/drug separately using J-codes (e.g., J1030 for methylprednisolone, J7321-J7327 for hyaluronic acid). CPT 20610 covers only the procedure, not the injectable agent.

    Impact: Medication can represent $15-$500+ additional reimbursement depending on the agent. Hyaluronic acid injections (J-codes) can exceed $200 per injection.

  3. When billing multiple joint injections on the same date, list the highest-valued joint first without modifier, then append modifier 59 to subsequent injections of different anatomic sites. Some payers apply multiple procedure reductions.

    Impact: Improper sequencing can trigger unnecessary reductions. Some payers reduce second injection by 50%, potentially reducing reimbursement by $21.99-$31.70 per additional injection.

  4. Document whether aspiration, injection, or both were performed. Include joint/bursa site, laterality, volume aspirated (if any), character of fluid, medication injected, dosage, and medical necessity for the procedure.

    Impact: Missing documentation elements are the leading cause of denials. Recovery rate for appeals with incomplete documentation is below 30%, costing the full $43.99-$63.40 per denial.

  5. For modifier 25 claims, ensure the E/M note clearly documents a separately identifiable service beyond the decision to inject. Document that the problem was evaluated, history taken, exam performed, and decision-making occurred independent of the injection.

    Impact: Modifier 25 denials occur in 20-30% of claims without proper documentation. Successfully supporting modifier 25 adds $50-$150 per encounter depending on E/M level billed.

  6. Verify frequency limitations with individual payers. Medicare and most commercial payers limit injections to the same joint to 3-4 times per year. Check LCD/NCD policies for coverage criteria.

    Impact: Exceeding frequency limits results in automatic denials. If performing injections more frequently than payer policy allows, obtain prior authorization or issue an ABN to transfer liability to patient.

Common denials

Medical necessity not established - payer requires documentation of conservative treatment failure before approving joint injections

How to appeal: Submit clinical notes showing prior treatment with NSAIDs, physical therapy, or other conservative measures for at least 4-6 weeks. Include imaging reports documenting arthritis or effusion. Cite LCD/NCD policies supporting injection for documented conditions.

Modifier 25 denial - E/M service bundled with procedure as not separately identifiable from decision to perform injection

How to appeal: Provide documentation clearly separating the E/M service from the injection decision. Highlight history, examination findings, and medical decision-making that would have occurred regardless of the injection. Reference CPT guidelines and CMS MLN Matters articles supporting modifier 25 for significant, separately identifiable E/M services.

Frequency limitation exceeded - same joint injected too frequently within payer-defined timeframe (typically more than 4 injections per year)

How to appeal: Provide medical records documenting unique medical circumstances requiring more frequent injections. Include specialist consultation notes supporting increased frequency. Request exception based on severity of condition or failure of standard treatment intervals. If no ABN was obtained, appeal may be unsuccessful.

Bundling denial when billed with trigger point injections (20552/20553) or other injection codes on same date of service

How to appeal: Submit documentation with anatomic diagrams showing distinct injection sites. Emphasize that 20610 involves intra-articular/bursal injection while trigger points are muscular. Use modifier 59 appropriately and reference NCCI edits demonstrating codes are not bundled when performed at distinct anatomic sites.

Frequently asked questions

What is the difference between CPT 20610 and 20611?

CPT 20610 is for joint/bursa aspiration or injection WITHOUT ultrasound guidance, while 20611 is the same procedure WITH ultrasound guidance. Code 20611 has higher reimbursement (2025 Medicare non-facility rate $88.83 vs. $63.40 for 20610) but requires documentation of ultrasound use, image storage, and a separate report. You cannot bill both codes together for the same joint.

How much does Medicare pay for CPT 20610 in 2025?

Medicare pays $63.40 for CPT 20610 in non-facility settings (physician office) and $43.99 in facility settings (hospital outpatient department or ASC) based on the 2025 national average. Actual payment varies by geographic location due to locality-specific adjustments. The total RVU is 1.96 multiplied by the 2025 conversion factor of 32.3465.

Can you bill an office visit and joint injection on the same day?

Yes, you can bill an E/M visit (99202-99215) with modifier 25 along with CPT 20610 on the same day, but only if the E/M service is significantly and separately identifiable from the injection procedure. The E/M must involve evaluation beyond simply deciding to perform the injection. Documentation must clearly support the separate nature of the services, or the E/M will be denied as bundled.

What joints are covered under CPT 20610?

CPT 20610 covers major joints and bursae including shoulder, hip, knee, ankle, elbow, wrist, and associated major bursae like subacromial and trochanteric bursae. For intermediate joints (acromioclavicular, temporomandibular, wrist), use CPT 20605. For small joints (fingers, toes), use CPT 20600. Using the wrong code for joint size is a common cause of denials and audit findings.

Can you bill 20610 for both aspiration and injection?

Yes, CPT 20610 includes both aspiration and injection when performed during the same encounter on the same joint. You bill the code only once regardless of whether you aspirate only, inject only, or both aspirate and inject. The descriptor 'Drain/inj joint/bursa' covers all scenarios. Document both components when performed to support medical necessity.

How do you bill for bilateral knee injections?

For bilateral knee injections performed on the same date, report CPT 20610 once with modifier 50 (bilateral procedure). Most payers reimburse at 150% of the single procedure rate. Alternatively, some payers prefer two line items: 20610-RT and 20610-LT. Check individual payer billing guidelines. Do not bill 20610 twice without modifiers, as the duplicate will be denied.

Is prior authorization required for CPT 20610?

Prior authorization requirements vary by payer and medication used. Most Medicare plans do not require prior authorization for the procedure itself (20610), but may require it for certain injectable drugs, especially viscosupplementation (hyaluronic acid) products. Many Medicare Advantage and commercial plans require prior authorization for injections beyond a certain frequency or for specific high-cost medications. Always verify with the specific payer before performing the procedure.

Reimbursement estimates for informational purposes only. Verify with CMS and individual payers before billing decisions. Updated for 2025.